Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2154835 | 0.97 | ACHE (0.50) | ACHELMNATSHRALOX12TDP1 | |
| P-Xylene SCHEMBL7638602 | 0.97 | ACHE (0.56) | ACHELMNATSHRALOX12TDP1 | |
| P-Xylene SCHEMBL7641776 | 0.94 | ACHE (0.53) | ACHELMNATSHRALOX12TDP1 | |
| Toluene SCHEMBL9464383 | 0.92 | ACHE (0.65) | ACHELMNATSHRALOX12TDP1 | |
| SCHEMBL883788 | 0.88 | ACHE (0.57) | ACHELMNATSHRALOX12TDP1 | |
| Water SCHEMBL28646976 | 0.85 | ACHE (0.53) | ACHELMNATSHRALOX12TDP1 | |
| SCHEMBL29083662 | 0.85 | ACHE (0.53) | ACHELMNATSHRALOX12TDP1 | |
| SCHEMBL29126101 | 0.85 | ACHE (0.53) | ACHELMNATSHRALOX12TDP1 | |
| Hydrochloric Acid SCHEMBL2153693 | 0.85 | ACHE (0.53) | ACHELMNATSHRALOX12TDP1 | |
| Fluoride SCHEMBL29226553 | 0.85 | ACHE (0.53) | ACHELMNATSHRALOX12TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3507263-A1 | EFFICIENT CATALYST FOR THE FORMATION OF POLYARYL HYDROCARBONS SUITABLE AS PRECURSORS FOR POLYDENTATE ORGANOPHOSPHORUS CATALYST LIGANDS | Eastman Chemical Company (US) | 2019-07-10 | — | — | EP | claimed |
| WO-2018044824-A1 | EFFICIENT CATALYST FOR THE FORMATION OF POLYARYL HYDROCARBONS SUITABLE AS PRECURSORS FOR POLYDENTATE ORGANOPHOSPHORUS CATALYST LIGANDS | EASTMAN CHEMICAL COMPANY (US) | 2018-03-08 | — | — | WO | claimed |
| CN-111315828-B | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2023-09-29 | — | — | CN | disclosed |
| CN-112154167-B | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2023-08-22 | — | — | CN | disclosed |
| CN-115746053-A | Si-PCCP ligand, preparation method thereof, ethylene oligomerization catalyst and application thereof | 万华化学集团股份有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-9704612-B2 | Composition of silver-conjugated compound composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| EP-1912953-B1 | PROCESS FOR THE SYNTHESIS OF ROSUVASTATIN CALCIUM | LEK PHARMACEUTICALS (SI) | 2016-08-17 | — | — | EP | disclosed |
| US-20140001422-A1 | COMPOSITION OF SILVER-CONJUGATED COMPOUND COMPOSITE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-02 | — | — | US | disclosed |
| US-8461248-B2 | Resin composition and molded product thereof, and method for their production | SONY CORPORATION (JP) | 2013-06-11 | — | — | US | disclosed |
| US-8354530-B2 | Preparation of HMG-CoA reductase inhibitors, in particular rosuvastatin calcium, introducing L-malic acid as source of chirality for side chain; statin core moiety is consecutively coupled with chiral segment containing 4 carbon atoms and segment containing 2 carbon atoms; treating hypercholesterolemia | Lek Pharmaceuticals d. d (SI) | 2013-01-15 | — | — | US | disclosed |
| EP-2230275-B1 | Resin composition and molded product thereof, and method for their production | SONY CORP (JP) | 2012-11-21 | — | — | EP | disclosed |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | disclosed |
| CN-1216059-C | Phosphonium salts, process for producing the same, use thereof, phosphine produced from the phosphonium salts and process for producing the same | KURARAY CO (JP) | 2005-08-24 | — | — | CN | disclosed |
| WO-2005040277-A1 | FLAME RETARDANT EPOXY PREPREGS, LAMINATES, AND PRINTED WIRING BOARDS OF ENHANCED THERMAL STABILITY | ALBEMARLE CORPORATION (US) | 2005-05-06 | — | — | WO | disclosed |
| US-20050075024-A1 | Flame retardant epoxy prepregs, laminates, and printed wiring boards of enhanced thermal stability | ALBEMARLE CORPORATION | 2005-04-07 | — | — | US | disclosed |
| US-6683136-B2 | OF A NITRILE COPOLYMER RUBBER, USING A HYDROGENATION CATALYST, A COCATALYST, AND A PROTON ACCEPTOR THAT IS NON-COORDINATING WITH THE METAL COMPLEX CATALYST, SUCH AS EPOXIDIZED SOYBEAN OIL (ESBO) | BAYER INC. (CA) | 2004-01-27 | — | — | US | disclosed |
| CN-1384106-A | Phosphonium salts, process for producing the same, use thereof, phosphine produced from the phosphonium salts and process for producing the same | KURARAY CO (JP) | 2002-12-11 | — | — | CN | disclosed |
| US-20020128393-A1 | Esbo enhanced hydrogenation | LANXESS INC. (CA) | 2002-09-12 | — | — | US | disclosed |
| US-4293502-A | CATALYST FOR OLIGOMERIZATION OF ETHYLENE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| US-3951661-A | Silver halide emulsion containing an arylphosphonium salt as antifoggant | KONISHIROKU PHOTO INDUSTRY CO. (JA) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | CCRL2, ARL1, OSBP2 | ACHE 4524/4885LMNA 755/4885TSHR 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.